# Determination of Blood Tumor Cells

> **NCT04290923** · — · COMPLETED · sponsor: **University of Zurich** · enrollment: 71 (actual)

## Conditions studied

- Leukemia, Lymphocytic, Chronic, B-Cell
- Abnormalities Cell Epithelial

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04290923
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-01
- **Primary completion:** 2022-10-26
- **Final completion:** 2022-12-30
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2023-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04290923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04290923, "Determination of Blood Tumor Cells". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04290923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*